Figure 1From: Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanomaAdvanced cutaneous malignant melanoma. Large exophytic skin melanoma on the left shoulder (Panel a); Left axillary and brachial metastatic masses (Panel b); reduction of the shoulder metastatic lesions by 60% after 1 week of Dabrafenib therapy (Panel c); Melanoma metastatic lesions completely disappeared after less than 1 month of therapy (Panel d)Back to article page